Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 15,000 shares at $101.06 ($1.5M) on 2017-07-10, disclosed to the SEC on 2017-07-11.
Open-market sale of $1.5M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.06 | 3,347 | $338K | 21.9% |
| 2 | $102.19 | 5,553 | $567K | 36.7% |
| 3 | $102.81 | 1,100 | $113K | 7.3% |
| 4 | $105.50 | 5,000 | $528K | 34.1% |
| Total | $103.09 avg | 15,000 | $1.5M | 100% |
| Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |
| KITE | SELL | 2017-04-27 | $2.5M | — | Filing → |